| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An instructive case, a difference of opinion
|
Schwartzberg, Lee S.
|
|
2007
|
4 |
6 |
p. 399-400
2 p.
|
artikel
|
| 2 |
Are drug rebates good for oncology?
|
Klepper, Brian R.
|
|
2007
|
4 |
6 |
p. 367-
1 p.
|
artikel
|
| 3 |
Cancer bills offer promise, gain momentum
|
|
|
2007
|
4 |
6 |
p. 420-
1 p.
|
artikel
|
| 4 |
Debunking the myths of reimbursement, rebates, and oncologists' motives
|
Coplon, Steven M.
|
|
2007
|
4 |
6 |
p. 419-
1 p.
|
artikel
|
| 5 |
Dose-independent synergistic response with gemcitabine and cisplatin in anthracycline-resistant breast cancer and reversal of resistance to gemcitabine with addition of paclitaxel
|
Gupta, Renuka
|
|
2007
|
4 |
6 |
p. 398-399
2 p.
|
artikel
|
| 6 |
ESAs: whatever happened to evidence-based medicine?
|
Henry, David H.
|
|
2007
|
4 |
6 |
p. 389-390
2 p.
|
artikel
|
| 7 |
How one payer has stimulated a change in ESA therapy
|
Newcomer, Lee
|
|
2007
|
4 |
6 |
p. 393-
1 p.
|
artikel
|
| 8 |
How ‘tech toys’ have helped one doctor run a more efficient practice
|
Fried, John J.
|
|
2007
|
4 |
6 |
p. 417-
1 p.
|
artikel
|
| 9 |
If insurers jump the gun on policy, patients and practices suffer
|
Holcombe, Dawn G.
|
|
2007
|
4 |
6 |
p. 394-
1 p.
|
artikel
|
| 10 |
Implementing a multisymptom chemotherapy risk assessment tool in two community oncology practices
|
Hwa, Charlotte
|
|
2007
|
4 |
6 |
p. 404-409
6 p.
|
artikel
|
| 11 |
Managing medical complications in patients with brain tumors
|
Rosenfeld, Myrna R.
|
|
2007
|
4 |
6 |
p. 411-416
6 p.
|
artikel
|
| 12 |
Minimizing vincristine misadministration
|
Pangilinan, Joanna Maudlin
|
|
2007
|
4 |
6 |
p. 379-
1 p.
|
artikel
|
| 13 |
Primary adenocarcinoma of the sigmoid colon diagnosed by uterine curettage: a case report
|
English, Cynthia Ann
|
|
2007
|
4 |
6 |
p. 402-403
2 p.
|
artikel
|
| 14 |
Rebates are not the whole story
|
Bosserman, Linda D.
|
|
2007
|
4 |
6 |
p. 369-370
2 p.
|
artikel
|
| 15 |
Riding the Capitol Hill roller coaster
|
Henry, David H.
|
|
2007
|
4 |
6 |
p. 358-
1 p.
|
artikel
|
| 16 |
The FDA spoke: now what?
|
Boccia, Ralph V.
|
|
2007
|
4 |
6 |
p. 392-393
2 p.
|
artikel
|
| 17 |
The run-up to the ESA controversy and where we go from here
|
Gleason, Kara J.
|
|
2007
|
4 |
6 |
p. 390-392
3 p.
|
artikel
|
| 18 |
Treatment considerations for today's elderly
|
Nelson, Marybeth
|
|
2007
|
4 |
6 |
p. 379-
1 p.
|
artikel
|
| 19 |
Treatment options for cutaneous T-cell lymphoma expand
|
Rhee, Jay
|
|
2007
|
4 |
6 |
p. 386-
1 p.
|
artikel
|
| 20 |
Vorinostat in cutaneous T-cell lymphoma
|
Abraham, Jame
|
|
2007
|
4 |
6 |
p. 384-385
2 p.
|
artikel
|
| 21 |
Vorinostat: pharmacoeconomic issues
|
Cumpston, Aaron
|
|
2007
|
4 |
6 |
p. 386-
1 p.
|
artikel
|
Tijdschrift beschrijving